首页> 外文期刊>Journal of Translational Medicine >Prednisolone has a positive effect on the kidney but not on the liver of brain dead rats: a potencial role in complement activation
【24h】

Prednisolone has a positive effect on the kidney but not on the liver of brain dead rats: a potencial role in complement activation

机译:泼尼松龙对死脑大鼠的肾脏有积极作用,但对肝脏没有积极作用:补体激活中的潜在作用

获取原文
           

摘要

Background Contradictory evidence has been published on the effects of steroid treatments on the outcomes of kidney and liver transplantation from brain dead (BD) donors. Our study aimed to evaluate this disparity by investigating the effect of prednisolone administration on BD rats. Methods BD induction was performed in ventilated rats by inflating a Fogarty catheter placed in the epidural space. Prednisolone (22.5 mg/kg) was administered 30 min prior to BD induction. After four hours of determination of BD: serum, kidney and liver tissues samples were collected and stored. RT-qPCR, routine biochemistry and immunohistochemistry were performed. Results Prednisolone treatment reduced circulating IL-6 and creatinine plasma levels but not serum AST, ALT or LDH. Polymorphonuclear influx assessed by histology, and inflammatory gene expression were reduced in the kidney and liver. However, complement component 3 (C3) expression was decreased in kidney but not in liver. Gene expression of HSP-70, a cytoprotective protein, was down-regulated in the liver after treatment. Conclusions This study shows that prednisolone decreases inflammation and improves renal function, whilst not reducing liver injury. The persistence of complement activation and the negative effect on protective cellular mechanisms in the liver may explain the disparity between the effects of prednisolone on the kidney and liver of BD rats. The difference in the molecular and cellular responses to prednisolone administration may explain the contradictory evidence of the effects of prednisolone on different organ types from brain dead organ donors.
机译:背景:关于类固醇治疗对脑死亡(BD)供体的肾脏和肝脏移植结果的影响,已经发表了相反的证据。我们的研究旨在通过研究泼尼松龙对BD大鼠的作用来评估这种差异。方法通过充气硬膜外腔内的Fogarty导管对通气大鼠进行BD诱导。 BD诱导前30分钟给予泼尼松龙(22.5 mg / kg)。在确定BD四个小时后:收集并存储血清,肾脏和肝脏组织样品。进行了RT-qPCR,常规生化和免疫组织化学。结果泼尼松龙治疗可降低循环IL-6和肌酐血浆水平,但不能降低血清AST,ALT或LDH。通过组织学评估的多形核细胞潮气和炎症基因的表达在肾脏和肝脏减少。但是,补体成分3(C3)的表达在肾脏中降低,但在肝脏中没有降低。治疗后肝脏中HSP-70(一种细胞保护蛋白)的基因表达下调。结论这项研究表明,泼尼松龙可减轻炎症反应并改善肾功能,而不会减轻肝损伤。补体激活的持久性和对肝脏保护性细胞机制的负面影响可能解释了泼尼松龙对BD大鼠肾脏和肝脏的影响之间的差异。对泼尼松龙给药的分子和细胞反应的差异可能解释了泼尼松龙对脑死亡器官供体的不同器官类型的影响的相反证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号